Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.28 (
chloramphenicol acetyltransferase
)
5,100
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
mts1
gene is specifically expressed in certain metastatic tumors but not in their nonmetastatic counterparts. It is also expressed in several normal cell and tissue types that exhibit the ability to be motile. The gene was cloned from both mouse and human sources and the 5' flanking regions were sequenced. The sequencing data revealed a 135-base-pair region of high homology between the mouse and human
mts1
gene. This homology was observed in the vicinity of the TATA box. The 5' region of the
mts1
gene was also observed to have a high degree of homology to some known promoter and enhancer sequences. To determine the role this region plays in regulating the transcription of
mts1
, promoter analysis was performed. Sixteen constructs were prepared in which the
chloramphenicol acetyltransferase
gene was fused to different regions of the mouse
mts1
promoter. These constructs were analyzed in transient transfection assays in two related cell lines derived from mouse mammary adenosarcomas: CSML-0, a nonmetastatic cell line with low levels of
mts1
expression, and CSML-100, a metastatic cell line with high levels of
mts1
expression. Results of our transient transfection assays in conjunction with results obtained from in vitro and in vivo footprinting of the promoter region show no evidence of cis-acting control elements important for the transcriptional regulation of
mts1
in these cell lines. A few nucleotides upstream of the TATA box are sufficient for maximal levels of
mts1
transcription. Because no cis-acting control elements were found, restriction of
mts1
transcription in CSML-0 cells must exist on some other level.
mts1
was found to be hypermethylated in CSML-0 cells but not in CSML-100 cells. The possible role of methylation in progression of the nonmetastatic CSML-0 adenosarcoma cell line toward the metastatic CSML-100 adenosarcoma cell line is discussed.
...
PMID:Transcriptional analysis of the mts1 gene with specific reference to 5' flanking sequences. 132 89
The first intron of the
mts1
gene, a gene which is selectively expressed in metastatic cells and in normal cells that are motile, was found to be highly homologous to the CD3 delta enhancer element. Because of the homology between the CD3 delta enhancer and the first intron of
mts1
, we analysed the first intron of the
mts1
gene to determine whether it functions as a transcriptional regulatory element. Highly metastatic CSML-0 cells transfected with
chloramphenicol acetyltransferase
containing plasmids demonstrated the ability of the
mts1
first intron to function as a positive regulatory element. In vitro footprinting analysis using extracts from CSML-0 cells (which express
mts1
at low levels) of CSML-100 cells (which express
mts1
at high levels) identified a protected 16 nucleotide element in the first intron of
mts1
, regardless of the extract used. However, in vivo footprinting analysis of the same region identified the protected 16 nucleotide fragment only in the
mts1
intron from CSML-100 cells, not from CSML-0 cells. Differences in the methylation pattern of the
mts1
gene in CSML-100 cells and CSML-0 cells are known to exist, and may in part be responsible for the
mts1
footprinting differences observed in vivo from the different cells lines.
...
PMID:[Characteristics of a positive regulatory element in the first intron of the mts1 gene]. 146 40